98%
921
2 minutes
20
The diagnosis and treatment of acute pancreatitis remain challenging due to the limitations of diagnostic methods, which often result in delayed treatment and suboptimal outcomes. This underscores the need for innovative diagnostic strategies to enable early detection and improve therapeutic interventions. Electrochemiluminescence (ECL)-based biosensors have emerged as a promising solution, offering advantages such as cost-effectiveness, ease of use, and high sensitivity. This study introduces an innovative ECL biosensor design, which incorporates a DNA tetrahedron as a structural scaffold, a double swing arm mechanism for enhanced motion control, and a track-based signal regulation system. This design significantly enhanced the operating efficiency and controllability of DNA walkers. The system utilizes ferrocene (Fc) as a signal quenching agent, with its electrochemical signal restored upon interaction with miRNA24-3p, a biomarker for acute pancreatitis. The platform features a composite luminescent material─tris(2,2'-bipyridine) dichlororuthenium(II)@goldnanoparticles@single-walled carbon nanotubes (Ru(bpy)@AuNPs@SWCNTs)─and employs persulfate as a coreactant. Under optimized conditions, this design demonstrated a wide dynamic range (10 M to 10 M) and an ultralow detection limit of approximately 60 aM for miRNA 24-3p. Additionally, it exhibited excellent specificity, reproducibility, and stability. These findings underscore the potential of this application of this ECL-based platform to revolutionize the clinical diagnosis of acute pancreatitis by enabling more timely and accurate interventions while paving the way for advancements in diagnostic technologies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121624 | PMC |
http://dx.doi.org/10.1021/acs.analchem.5c01244 | DOI Listing |
Int J Biol Macromol
September 2025
Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Pancreatology
August 2025
Department of Dermatology, The People's Hospital of Rongchang District, Chongqing, China. Electronic address:
Gastrointest Endosc
September 2025
Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:
BMJ Open Gastroenterol
September 2025
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Noord-Holland, The Netherlands
Objective: Patients with acute pancreatitis show reduced gut microbiome diversity and high abundance of pathogenic bacteria compared with healthy subjects. Admission microbiome profiles are increasingly linked to severity, but methodology and study quality hamper interpretation. Our aim was to investigate whether admission microbiome analysis provides robust and reproducible associations with severity and complications of acute pancreatitis.
View Article and Find Full Text PDFJ Ethnopharmacol
September 2025
Department of Emergency Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China. Electronic address:
Ethnopharmacological Relevance: Liquorice (Gancao), a classic Chinese herb, has been historically prescribed for inflammation and gastrointestinal disorders. Its bioactive flavonoid liquiritigenin (4',7-dihydroxyflavone) exhibits anti-inflammatory properties, yet its efficacy against acute pancreatitis (AP) remains unexplored.
Aim: To systematically investigate the therapeutic potential of liquiritigenin against AP and decipher its estrogen receptor beta (ERβ)-mediated mitochondrial regulatory mechanisms.